Stocks · Health care · Pharmaceutical Preparations

Sagimet Biosciences Inc.

SGMT Clue Score32
United States Fiscal year ends December CIK 0001400118 Results filed 11 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George Kemble
20 Jul 2026
Director
Sold on a plan
18,844
$7.46
$140.53K
George Kemble
20 Nov 2025
Executive Chairman
Sold on a plan
37,688
$7.69
$289.98K

What was left out

Form 4 filings counted 26
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 2
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 631,193
History held since 20 Jul 2023